GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » 5-Year Yield-on-Cost %

IPA (ImmunoPrecise Antibodies) 5-Year Yield-on-Cost % : 0.00 (As of Mar. 24, 2025)


View and export this data going back to 2011. Start your Free Trial

What is ImmunoPrecise Antibodies 5-Year Yield-on-Cost %?

ImmunoPrecise Antibodies's yield on cost for the quarter that ended in Oct. 2024 was 0.00.


The historical rank and industry rank for ImmunoPrecise Antibodies's 5-Year Yield-on-Cost % or its related term are showing as below:



IPA's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.6
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of ImmunoPrecise Antibodies's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, ImmunoPrecise Antibodies's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ImmunoPrecise Antibodies's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunoPrecise Antibodies's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where ImmunoPrecise Antibodies's 5-Year Yield-on-Cost % falls into.



ImmunoPrecise Antibodies 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of ImmunoPrecise Antibodies is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

ImmunoPrecise Antibodies  (NAS:IPA) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


ImmunoPrecise Antibodies 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunoPrecise Antibodies Business Description

Traded in Other Exchanges
Address
3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.